ReviewThe FEBS journal2020
COVID-19 breakthroughs: separating fact from fiction.
Review in The FEBS journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 40 citations in OpenAlex.
- Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker.Redox biology · 2021Trial
- Association between coronavirus 2 infection and preeclampsia among unvaccinated women.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2025Article
- Mitigating the identity and health threat of COVID-19: Perspectives of middle-class South Asians living in the UK.Journal of health psychology · 2022Article
- Perceived accessibility, and adequacy of COVID-19 related information in Nigeria.Journal of public health in Africa · 2022Article
- 'It's possibly made us feel a little more alienated': How people from ethnic minority communities conceptualise COVID-19 and its influence on engagement with testing.Journal of health services research & policy · 2022Article
- Association of Built Environmental Features with Rates of Infectious Diseases in Remote Indigenous Communities in the Northern Territory, Australia.Healthcare (Basel, Switzerland) · 2022Article
- Spotlight on COVID-19: eighteen months on.The FEBS journal · 2021Article
- COVID-19-associated venous thromboembolism portends worse survival.Seminars in vascular surgery · 2021Article
- COVID-19 vaccines: what do we know so far?The FEBS journal · 2021Article
- Maintaining human milk bank services throughout the COVID-19 pandemic: A global response.Maternal & child nutrition · 2021Article
- A preparedness model for the provision of oral health care during unfolding threats: the case of the covid-19 pandemic.BMC oral health · 2021Article
- Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes.ERJ open research · 2021Article
- SARS-CoV-2 Infection Among Health Care Workers Despite the Use of Surgical Masks and Physical Distancing-the Role of Airborne Transmission.Open forum infectious diseases · 2021Article
- The Role of the Health Coach in a Global Pandemic.Global advances in health and medicine · 2021Article
- Nicotine Changes Airway Epithelial Phenotype and May Increase the SARS-COV-2 Infection Severity.Molecules (Basel, Switzerland) · 2020Article
- Investigating the Prevalence of Reactive Online Searching in the COVID-19 Pandemic: Infoveillance Study.Journal of medical Internet research · 2020Article
- Nicotine and the nicotinic cholinergic system in COVID-19.The FEBS journal · 2020Review
- A Glimpse of the First Eight Months of the COVID-19 Literature on Microsoft Academic Graph: Themes, Citation Contexts, and Uncertainties.Frontiers in research metrics and analytics · 2020Article
- The possible benefits of vitamin D in COVID-19.Nutrition (Burbank, Los Angeles County, Calif.)Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The newly recognised coronavirus SARS-CoV-2, causative agent of coronavirus disease (COVID-19), has caused a pandemic with huge ramifications for human interactions around the globe. As expected, research efforts to understand the virus and curtail the disease are moving at a frantic pace alongside the spread of rumours, speculations and falsehoods. In this article, we aim to clarify the current scientific view behind several claims or controversies related to COVID-19. Starting with the origin of the virus, we then discuss the effect of ibuprofen and nicotine on the severity of the disease. We highlight the knowledge on fomites and SARS-CoV-2 and discuss the evidence and explications for a disproportionately stronger impact of COVID-19 on ethnic minorities, including a potential protective role for vitamin D. We further review what is known about the effects of SARS-CoV-2 infection in children, including their role in transmission of the disease, and conclude with the science on different mortality rates between different countries and whether this hints at the existence of more pathogenic cohorts of SARS-CoV-2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.